BPH Global (ASX:BP8) 9-Day RSI: 44.41 (As of Jul. 06, 2026)


What is BPH Global 9-Day RSI?

BPH Global ASX:BP8 -25.00% 9-Day RSI is 44.41 as of Jul. 06, 2026. The stock has 6 warning signs investors should review. Among 1,047 Drug Manufacturers companies, BPH Global ranks worse than 60.17% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-06), BPH Global's 9-Day RSI is 44.41.

The industry rank for BPH Global's 9-Day RSI or its related term are showing as below:

ASX:BP8's 9-Day RSI is ranked worse than
60.17% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 54.19 vs ASX:BP8: 44.41

BPH Global  (ASX:BP8) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

BPH Global 9-Day RSI Related Terms

ASX:BP8 vs ZTS, UTHR: 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BPH Global 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where BPH Global's 9-Day RSI falls into.


BPH Global  (ASX:BP8) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 44.41 mean?
BPH Global (ASX:BP8) has a 9-Day RSI of 44.41 as of Jul. 06, 2026. According to the industry distribution chart, BPH Global ranks #630 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 60.2%.
Is BPH Global's 9-Day RSI too high?
BPH Global's current 9-Day RSI is 44.41. The Drug Manufacturers industry median 9-Day RSI is 54.19. BPH Global's value of 44.41 is 18% below this industry median. Based on the distribution chart, BPH Global ranks #630 out of 1047 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does BPH Global's 9-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, BPH Global ranks #630 out of 1047 companies for 9-Day RSI. This places BPH Global in the lower half of its industry. The industry median 9-Day RSI is 54.19. BPH Global's value of 44.41 is 18% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 54.19, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BPH Global's current 9-Day RSI of 44.41 is 18% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 54.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BPH Global's current 9-Day RSI is 44.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current 9-Day RSI of 44.41. The current 9-Day RSI is 44.41 and 18% below the Drug Manufacturers industry median of 54.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current 9-Day RSI is 44.41 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BPH Global Business Description

Other Exchanges USZ0:Germany
Address 96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.